Sheaff Brock Investment Advisors LLC Takes $225,000 Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)
Sheaff Brock Investment Advisors LLC bought a new stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 5,540 shares of the biopharmaceutical company’s stock, valued at approximately $225,000. Several other institutional investors also recently […]
More Stories
Eaton Vance California Municipal Income Trust (NYSE:CEV) Major Shareholder Sells $282,451.70 in Stock
Eaton Vance California Municipal Income Trust (NYSE:CEV – Get Free Report) major shareholder Saba Capital Management, L.P. sold 25,913 shares...
Insider Selling: Block, Inc. (NYSE:SQ) CFO Sells 5,935 Shares of Stock
Block, Inc. (NYSE:SQ – Get Free Report) CFO Amrita Ahuja sold 5,935 shares of the firm’s stock in a transaction...
Insider Selling: ACV Auctions Inc. (NASDAQ:ACVA) Insider Sells $321,155.10 in Stock
ACV Auctions Inc. (NASDAQ:ACVA – Get Free Report) insider Michael Waterman sold 16,098 shares of the stock in a transaction...
Hippo Holdings Inc. (NYSE:HIPO) Chairman Sells $198,327.50 in Stock
Hippo Holdings Inc. (NYSE:HIPO – Get Free Report) Chairman Assaf Wand sold 12,250 shares of the stock in a transaction...
Katapult (NASDAQ:KPLT) Upgraded at Cantor Fitzgerald
Cantor Fitzgerald upgraded shares of Katapult (NASDAQ:KPLT – Free Report) to a hold rating in a research report released on...
LiqTech International (NASDAQ:LIQT) Earns Sell Rating from Analysts at StockNews.com
StockNews.com began coverage on shares of LiqTech International (NASDAQ:LIQT – Free Report) in a report released on Thursday morning. The...